{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T11:13:58Z","timestamp":1697886838057},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"vor","delay-in-days":8053,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[1984,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A retrospective analysis of the treatment results and complications in 140 patients with advanced (Stage IIB or more) invasive cervical cancer treated at the Albert Einstein College of Medicine (AECOM) from 1962\u20131970 and the State University of New York at Buffalo (SUNYAB) from 1974\u20131982 is the subject of this report. All patients were clinically staged and received external pelvic radiotherapy followed by one to two intracavitary radium insertions, and those with histologically proven positive para\u2010aortic nodes received on additional 4,500 to 5,000 rads to the para\u2010aortic areas. Forty\u2010four patients had pretherapy surgical staging (26 transperitoneal, 18 extraperitoneal). In the clinical staging group, a survival time of 5 years or longer was attained in 22 of 39 patients (56%); with Stage IIB, 11 of 30 patients (37%) with Stage IIIA, two of 13 patients with Stage IIIB and two of 12 patients with Stage IVA disease. Of 26 patients staged via transperitoneal approach, two survived more than 5 years and three others were alive at last contact (after more than 3 years follow\u2010up). The last 18 patients have been subjected to laparoscopy and retroperitoneal pelvic and para\u2010aortic node biopsies followed by tailored radiotherapy with [12] or without [6] chemotherapy. Chemotherapy consisted of alternating weekly courses of vincristine and bleomycin and hydroxyurea. Mitomycin\u2010C was added to this regimen at the conclusion of the course of radiotherapy. Only one patient developed a vesicovaginal fistula. At last contact, seven patients in the combined therapy group were alive and free of disease. Combined therapy following extraperitoneal surgical staging appears to be feasible and justifiable. It deserves further trials in larger series.<\/jats:p>","DOI":"10.1002\/jso.2930260305","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T09:03:40Z","timestamp":1171962220000},"page":"161-167","source":"Crossref","is-referenced-by-count":1,"title":["Treatment of advanced invasive cervical cancer: Changing times and trends"],"prefix":"10.1002","volume":"26","author":[{"given":"Mahmood","family":"Yoonessi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"BarberHRK:Is staging laparotomy for cancer of the cervix justified? Editorial The Female Patient March 1979."},{"key":"e_1_2_1_3_2","volume-title":"Cancer Statistics,1980","author":"Carfinkel L"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.33.1.2"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841867709133952"},{"key":"e_1_2_1_6_2","first-page":"2030","article-title":"Surgical staging of gynecologic cancer","volume":"78","author":"Yoonessi M","year":"1978","journal-title":"NYState J Med"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1148\/88.5.961"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1148\/15.3.681"},{"key":"e_1_2_1_9_2","first-page":"17","article-title":"The value of pretherapy para\u2010aortic lymphadenectomy for carcinoma of the cervix uteri","volume":"145","author":"Piver MS","year":"1977","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_1_10_2","first-page":"658","article-title":"The operative evaluation of patients with cervical carcinoma by an extraperitoneal approach","volume":"50","author":"Berman ML","year":"1977","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9378(79)90118-2","article-title":"Extrapelvic lymph node metastases in cervical carcinoma","volume":"133","author":"Buschsbaum HJ","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_12_2","first-page":"333","article-title":"Pre\u2010irradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix","volume":"49","author":"Wharton JR","year":"1977","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(80)90013-X"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(74)90483-9"},{"key":"e_1_2_1_15_2","first-page":"90","article-title":"Survival after extraperitoneal pelvic and para\u2010aortic lymphade\u2010nectomy and radiation therapy in cervical carcinoma","volume":"57","author":"Ballon SC","year":"1981","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(78)90076-7"},{"key":"e_1_2_1_17_2","first-page":"708","article-title":"Laparoscopy in the evaluation of gynecologic cancer","volume":"52","author":"Lacey CG","year":"1978","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(49)90200-8"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(79)91209-4"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197703)39:3<1243::AID-CNCR2820390333>3.0.CO;2-T"},{"key":"e_1_2_1_21_2","first-page":"146","article-title":"Mitomycin\u2010C, Vincristine and Bleomycin therapy for advanced cervical cancer","volume":"52","author":"Baker LH","year":"1978","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_22_2","first-page":"333","article-title":"Bleomycin. A review","volume":"7","author":"Crooke ST","year":"1976","journal-title":"J Med"},{"issue":"32","key":"e_1_2_1_23_2","first-page":"244","article-title":"Weintraubl: Combined Bleomycin (B) and x\u2010radiation therapy (XRT) for advanced cervix carcinoma (ACC)","volume":"17","author":"Byfield JE","year":"1976","journal-title":"Proc Am Assoc Cancer Res Am Soc Clin Oncol"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.2930260305","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.2930260305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:54:48Z","timestamp":1697777688000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.2930260305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,7]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1984,7]]}},"alternative-id":["10.1002\/jso.2930260305"],"URL":"https:\/\/doi.org\/10.1002\/jso.2930260305","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,7]]}}}